AnaptysBio (ANAB) PT Lowered to $28 at JPMorgan
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $57.74 +1.85%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on AnaptysBio (NASDAQ: ANAB) to $28.00 (from $30.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
- Agilent (A) PT Raised to $150 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
